Figure 2
From: Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3
Cutoff value for the proposed Affimer-MAb CLIA assay. (A) Frequency distribution of GPC3 concentrations in a healthy population (n = 196). (B) The ROC curve of the proposed Affimer-MAb CLIA assay (n = 276). Green line represents the diagnostic reference line; blue line represents the ROC curve of GPC3.
